FilingPulse

CODX insider transaction filings

Co-Diagnostics, Inc. — 28 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-05-27. Screen CODX transaction legs live →

FiledFormInsiderReported transactionsSource
2026-05-274Abbott Richard David — PresidentGrant/award (A): 1,890 @ $0 · Disposition to issuer (D): 680 @ $5.07 · Option exercise (M): 1,890 (derivative) @ $0EDGAR
2026-05-274Brown Brian Lee — Chief Financial OfficerGrant/award (A): 3,750 @ $0 · Disposition to issuer (D): 1,350 @ $5.07 · Option exercise (M): 3,750 (derivative) @ $0EDGAR
2026-05-274Durenard Eugene — DirectorGrant/award (A): 1,695 @ $0 · Option exercise (M): 1,695 (derivative) @ $0EDGAR
2026-05-274Murphy Edward L. — DirectorGrant/award (A): 1,695 @ $0 · Option exercise (M): 1,695 (derivative) @ $0EDGAR
2026-05-274Egan Dwight H — Chief Executive Officer, DirectorGrant/award (A): 4,584 @ $0 · Disposition to issuer (D): 1,633 @ $5.07 · Option exercise (M): 4,584 (derivative) @ $0EDGAR
2026-05-274NELSON JAMES B — DirectorGrant/award (A): 1,695 @ $0 · Option exercise (M): 1,695 (derivative) @ $0EDGAR
2026-05-274SERBIN RICHARD S — DirectorGrant/award (A): 1,695 @ $0 · Option exercise (M): 1,695 (derivative) @ $0EDGAR
2025-11-244Abbott Richard David — PresidentGrant/award (A): 56,667 @ $0 · Disposition to issuer (D): 17,200 @ $0.35 · Option exercise (M): 56,667 (derivative) @ $0EDGAR
2025-11-244Brown Brian Lee — Chief Financial OfficerGrant/award (A): 134,167 @ $0 · Disposition to issuer (D): 40,723 @ $0.35 · Option exercise (M): 134,167 (derivative) @ $0EDGAR
2025-11-244Durenard Eugene — DirectorGrant/award (A): 57,499 @ $0 · Option exercise (M): 57,499 (derivative) @ $0EDGAR
2025-11-244Murphy Edward L. — DirectorGrant/award (A): 57,499 @ $0 · Option exercise (M): 57,499 (derivative) @ $0EDGAR
2025-11-244Egan Dwight H — Chief Executive Officer, DirectorGrant/award (A): 163,333 @ $0 · Disposition to issuer (D): 49,575 @ $0.35 · Option exercise (M): 163,333 (derivative) @ $0EDGAR
2025-11-244NELSON JAMES B — DirectorGrant/award (A): 57,499 @ $0 · Option exercise (M): 57,499 (derivative) @ $0EDGAR
2025-11-244SERBIN RICHARD S — DirectorGrant/award (A): 57,499 @ $0 · Option exercise (M): 57,499 (derivative) @ $0EDGAR
2025-08-154Abbott Richard David — PresidentGrant/award (A): 220,000 (derivative) @ $0EDGAR
2025-08-154Brown Brian Lee — Chief Financial OfficerGrant/award (A): 225,000 (derivative) @ $0EDGAR
2025-08-154Egan Dwight H — Chief Executive Officer, DirectorGrant/award (A): 275,000 (derivative) @ $0EDGAR
2025-08-154Durenard Eugene — DirectorGrant/award (A): 125,000 (derivative) @ $0EDGAR
2025-08-154MURPHY TED — DirectorGrant/award (A): 125,000 (derivative) @ $0EDGAR
2025-08-154NELSON JAMES B — DirectorGrant/award (A): 125,000 (derivative) @ $0EDGAR
2025-08-154SERBIN RICHARD S — DirectorGrant/award (A): 125,000 (derivative) @ $0EDGAR
2025-05-274Egan Dwight H — Chief Executive Officer, DirectorGrant/award (A): 163,334 @ $0 · Disposition to issuer (D): 51,697 @ $0.24 · Option exercise (M): 163,334 (derivative) @ $0EDGAR
2025-05-274Brown Brian Lee — Chief Financial OfficerGrant/award (A): 134,166 @ $0 · Disposition to issuer (D): 48,161 @ $0.24 · Option exercise (M): 134,166 (derivative) @ $0EDGAR
2025-05-274Abbott Richard David — PresidentGrant/award (A): 20,000 @ $0 · Disposition to issuer (D): 7,180 @ $0.24 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2025-05-274Durenard Eugene — DirectorGrant/award (A): 48,334 @ $0 · Option exercise (M): 48,334 (derivative) @ $0EDGAR
2025-05-274MURPHY TED — DirectorGrant/award (A): 48,334 @ $0 · Option exercise (M): 48,334 (derivative) @ $0EDGAR
2025-05-274NELSON JAMES B — DirectorGrant/award (A): 48,334 @ $0 · Option exercise (M): 48,334 (derivative) @ $0EDGAR
2025-05-274SERBIN RICHARD S — DirectorGrant/award (A): 48,334 @ $0 · Option exercise (M): 48,334 (derivative) @ $0EDGAR

Recent 8-K events — Co-Diagnostics, Inc.

FiledFormItems reportedSource
2026-08-138-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-318-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-278-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-218-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-148-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-318-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-108-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events		EDGAR
2026-01-138-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2025-12-308-K3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2025-12-058-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CODX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →